Clinical Trial Update: Efficacy of Rapamycin (Sirolimus) in the Treatment of BRBNS, Hereditary or Sporadic Venous Malformation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating rapamycin (sirolimus) for Blue Rubber Bleb Nevus Syndrome and venous malformations with unclear status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blue Rubber Bleb Nevus Syndrome
• Venous Malformation

Drugs mentioned

• Rapamycin (sirolimus)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Blue Rubber Bleb Nevus Syndrome, Venous Malformation | Phase 4 | Status: UNKNOWN